Aligned Genetics, Inc.

KOSDAQ:A238120 株式レポート

時価総額：₩47.3b

Aligned Genetics マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Yeon-Cheol Jung

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権20.5%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit

Nov 20
Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit

Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Aug 12
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06
If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11
Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

CEO（最高経営責任者

Yeon-Cheol Jung (54 yo)

no data

在職期間

Mr. Yeon-Cheol Jung serves as the Chief Executive Officer at Aligned Genetics, Inc. (formerly known as Logos Biosystems, Inc.). Mr. Jung is an Insider at Aligned Genetics, Inc. (formerly known as Logos Bio...